Janssen Pharmaceutica
(Janssen Research & Development, Johnson & Johnson, J&J, Johnson & Johnson Innovative Medicine, J&J Innovative Medicine)
Turnhoutseweg 30
2340 Beerse
BE
Public Limited Company
Juridical SituationNormal situation
Established10/23/1934
Large
Information service activities
Architectural and engineering activities; technical testing and analysis
Manufacture of basic pharmaceutical products and pharmaceutical preparations
Sentiment Attention Over Time
The Sentiment Attention is produced by AI models developed by Sentometrics. Articles are connected to companies based on public information like company names, sectors, locations, linked companies, and company directors. Themes are assigned using keywords, and sentiment is analyzed with the help of AI prompts. A human team reviews and helps the system learn and improve over time.
Recent Relevant News
| Date | Sentiment | Theme | Headline | Source |
|---|---|---|---|---|
Date 7/2/2026 | Sentiment Positive | Theme Financial health Environmental Social Governance | Title Positive Update - Feb 07 | Source Source 1 |
Date 7/2/2026 | Sentiment Positive | Theme Environmental | Title Positive Update - Feb 07 | Source Source 2 |
Date 6/2/2026 | Sentiment Positive | Theme Environmental Financial health | Title Positive Update - Feb 06 | Source Source 3 |
Date 27/1/2026 | Sentiment Positive | Theme Financial health | Title Positive Update - Jan 27 | Source Source 4 |
Date 30/9/2025 | Sentiment Positive | Theme Financial health | Title Positive Update - Sep 30 | Source Source 5 |
Unlock 25+ years of newsUnlock | ||||
Often Mentioned With
Company Network
Financials
as of 31/12/2024
Key highlights
- Janssen Pharmaceutica turnover remained stable at €22.6B, maintaining a net result of €2.6B (12% margin, 25% ROE).
- Financial position remains balanced with total assets of €20.9B and a solvency ratio of 50%.
- Workforce efficiency is strong with 5,2K FTE generating an average turnover of €4.3M per employee.